LiveCellAnalysis System

LiveCellAnalysis System is an advanced microfluidic platform engineered to replicate the complex microenvironment and physiological functions of human organs in vitro. Built on state-of-the-art microfabrication technology, this device creates biomimetic three-dimensional microchannel networks with dynamic perfusion capabilities that faithfully reproduce in vivo fluid shear forces, nutrient gradients, and metabolic waste clearance.

The core architecture features a multi-layer chip design comprising an upper cell culture chamber, a lower perfusion channel, and a biomimetic porous membrane interface that simulates tissue-vascular boundaries. This configuration supports both single-cell-type 3D cultures and modular multi-cell-type co-culture systems, enabling construction of physiologically complete micro-organ systems such as liver metabolic units, kidney filtration barriers, blood-brain barriers, intestinal absorption models, and tumor microenvironments.

Key advantages over conventional 2D cultures include: establishment of proper cell polarity and tight junctions; functional protein expression at physiologically relevant levels; real-time monitoring capabilities; precise control of microenvironmental parameters; and compatibility with high-resolution imaging systems. Compared to animal models, organ-on-chip technology offers human-cell-based data, shorter experimental timelines, lower costs, and enhanced parameter control while supporting the 3Rs principle (Replacement, Reduction, Refinement of animal use).

The platform is manufactured using biocompatible materials with optical-grade transparency for high-quality imaging, ANSI/SLAS standard dimensions for equipment compatibility, and anti-evaporation designs to eliminate edge effects in long-term cultures.

LiveCellAnalysis System serves as a next-generation microphysiological system (MPS) with multiple core functions for biomedical research and pharmaceutical development:

1. **Biomimetic 3D Cell Culture**: Supports physiologically relevant three-dimensional cell architectures with proper polarization, cell-cell junctions, and tissue-specific spatial organization that cannot be achieved in traditional 2D cultures.

2. **Dynamic Microenvironment Control**: Enables precise regulation of perfusion rates, oxygen tension, cytokine concentrations, and mechanical forces (shear stress, cyclic stretch) to simulate healthy and pathological conditions.

3. **Real-time Non-invasive Monitoring**: Compatible with live-cell imaging, TEER measurements, and online biosensors for continuous assessment of barrier integrity, metabolic activity, and cellular responses.

4. **Multi-organ Integration**: Modular design supports connection of multiple organ chips through microfluidic linkers to simulate systemic drug distribution, metabolism, and organ-organ interactions in multi-organ systems.

5. **Drug Discovery Applications**: Provides more accurate prediction of ADME properties, toxicity profiles, and efficacy data compared to conventional models. Particularly valuable for hepatotoxicity, cardiotoxicity, nephrotoxicity, and CNS penetration assessments.

6. **Disease Modeling**: Supports construction of tumor microenvironments, inflammatory models, fibrosis progression, infectious disease models, and patient-specific personalized disease models using patient-derived cells.

7. **Regulatory Acceptance**: Organ-on-chip data is increasingly recognized by regulatory agencies (FDA, EMA) as complementary evidence in drug approval packages, supporting the transition toward animal-free safety assessment strategies.

**Setup Protocol**:

**Step 1: Chip Preparation**
- Inspect chip for structural integrity upon receipt
- Rinse channels with sterile PBS to remove storage solution
- Apply ECM coating (Matrigel, collagen, or fibronectin) to culture chambers
- Incubate at 37°C for 1-2 hours

**Step 2: Cell Seeding**
- Harvest and count target cells
- Adjust density to recommended range (typically 1×10⁶ to 5×10⁶ cells/mL)
- Slowly inject cell suspension into upper chamber through dedicated ports
- For barrier models, seed different cell types in upper and lower chambers
- Static incubate for 2-4 hours before initiating perfusion

**Step 3: Perfusion Setup**
- Connect chip to gravity-driven system or external pump
- Set flow rate based on model type (typically 1-60 μL/min)
- Use complete culture medium as perfusate
- Monitor for bubbles and leaks during startup

**Step 4: Experimental Monitoring**
- Perform daily visual inspection using inverted microscopy
- Collect perfusate samples for biomarker analysis
- Record TEER values for barrier models
- Maintain sterile conditions throughout the experiment

**Key Notes**: All connections must be secure to prevent leaks. Bubble traps are recommended. Media reservoirs should be changed every 2-3 days for long-term cultures.